We are live on
!
Find out more
FCOMV
Foresite Capital Opportunity Management V Portfolio holdings
AUM
$33.3M
1-Year Est. Return
47.04%
This Fund
S&P 500
This Quarter
Est. Return
-22.14%
1 Year Est. Return
-47.04%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$39.7M
AUM Growth
-$31.7M
(-44%)
Cap. Flow
-$4.95M
Cap. Flow
% of AUM
-12.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
2
Reduced
1
Closed
2
Top Buys
| 1 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
+$4.05M |
| 2 |
Hims & Hers Health
HIMS
|
+$1.31M |
| 3 |
Compass Therapeutics
CMPX
|
+$986K |
Top Sells
| 1 |
HLTH
Cue Health Inc. Common Stock
HLTH
|
+$4.14M |
| 2 |
Quantum-Si Incorporated
QSI
|
+$3.69M |
| 3 |
Cullinan Oncology
CGEM
|
+$3.46M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $16M | 40.44% |
5,227,307
| – | – |
|
|
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $5.3M | 13.37% |
959,275
+490,455
| +105% | +$4.05M |
|
|
3
Compass Therapeutics
CMPX
$407M
| $4.12M | 10.38% |
1,554,250
+454,250
| +41% | +$986K |
|
4
Disc Medicine
IRON
$2.9B
| $4.12M | 10.37% |
81,171
| – | – |
|
|
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $3.68M | 9.27% |
291,667
| – | – |
|
6
Adicet Bio
ACET
$79.9M
| $2.48M | 6.26% |
10,625
| – | – |
|
|
7
Quantum-Si Incorporated
QSI
$189M
| $1.47M | 3.7% |
633,626
-964,499
| -60% | -$3.69M |
|
|
8
Hims & Hers Health
HIMS
$7.96B
| $1.39M | 3.5% |
+306,431
| New | +$1.31M |
|
9
Enanta Pharmaceuticals
ENTA
$397M
| $1.07M | 2.71% |
22,750
| – | – |
|
|
10
Cullinan Oncology
CGEM
$1.1B
| – | – |
-330,836
| Closed | -$3.46M |
|
|
HLTH
11
DELISTED
Cue Health Inc. Common Stock
HLTH
| – | – |
-641,483
| Closed | -$4.14M |
|
Similar funds
SHI
SAM
LUGPSI
KXA
PGM
ACM
KCM
ALFIA